Determination of pd-l1 expression in circulating tumor cells of nsclc patients and correlation with response to pd-1/pd-l1 inhibitors

HIGHLIGHTS

• who: Melanie Janning and colleagues from the Department of Oncology, Hematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald University Comprehensive Cancer Center Hamburg, University Medical Center Boehringer Ingelheim Pharma GmbH and CoKG, Biberach, Germany have published the Article: Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors, in the Journal: (JOURNAL)
• what: The authors report a method for PD-L1 staining of Parsortix-enriched CTCs and show that the PD-L1 status of CTCs does not correlate with the PD . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.